Braidwell’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1M Hold
1,100,370
0.78% 51
2026
Q1
$17.5M Hold
1,100,370
0.58% 59
2025
Q4
$19.5M Sell
1,100,370
-7,400
-0.7% -$130K 0.63% 53
2025
Q3
$20.5M Hold
1,107,770
0.61% 45
2025
Q2
$23.8M Hold
1,107,770
0.81% 35
2025
Q1
$27.3M Hold
1,107,770
0.96% 39
2024
Q4
$25.7M Hold
1,107,770
0.76% 45
2024
Q3
$30M Hold
1,107,770
0.85% 43
2024
Q2
$31.9M Hold
1,107,770
1% 38
2024
Q1
$32.3M Hold
1,107,770
1.04% 37
2023
Q4
$36M Buy
1,107,770
+50,000
+5% +$1.45M 1.32% 30
2023
Q3
$33.8M Buy
1,057,770
+296,562
+39% +$11.4M 1.07% 38
2023
Q2
$33.4M Sell
761,208
-237,663
-24% -$11M 1.09% 34
2023
Q1
$44.2M Sell
998,871
-45,828
-4% -$2.03M 1.46% 25
2022
Q4
$41.5M Buy
+1,044,699
New +$43.5M 1.39% 25

Other funds holding KIDS

Braidwell's KIDS Position: Q2 2026 in Review

Braidwell held its OrthoPediatrics (KIDS) position steady in Q2 2026 at 1,100,370 shares worth $21.1M. The position accounts for 0.78% of the portfolio, ranked #51.

Braidwell first reported a position in KIDS in Q4 2022 and has held it in 15 quarters since. The position peaked at $44.2M in Q1 2023. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Braidwell held 1,100,370 shares of OrthoPediatrics worth $21.1M as of Q2 2026.
  • Braidwell left its OrthoPediatrics share count unchanged in Q2 2026.
  • OrthoPediatrics made up 0.78% of Braidwell's portfolio in Q2 2026, its #51 holding.
  • Braidwell first reported a position in OrthoPediatrics in Q4 2022 and has held it in 15 quarters since.
  • Braidwell's OrthoPediatrics position peaked at $44.2M in Q1 2023.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.